X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4927) 4927
Publication (604) 604
Book Review (58) 58
Book Chapter (21) 21
Conference Proceeding (12) 12
Magazine Article (4) 4
Dissertation (3) 3
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
progression-free survival (3923) 3923
humans (3422) 3422
index medicus (3006) 3006
oncology (2664) 2664
female (2194) 2194
middle aged (1884) 1884
male (1855) 1855
aged (1654) 1654
adult (1395) 1395
chemotherapy (1321) 1321
cancer (1319) 1319
prognosis (1135) 1135
treatment outcome (1110) 1110
disease-free survival (1069) 1069
survival (1005) 1005
overall survival (846) 846
retrospective studies (760) 760
care and treatment (759) 759
antineoplastic combined chemotherapy protocols - therapeutic use (747) 747
aged, 80 and over (685) 685
hematology (674) 674
metastasis (643) 643
antineoplastic agents - therapeutic use (571) 571
therapy (542) 542
analysis (537) 537
research (486) 486
patients (477) 477
tumors (468) 468
neoplasm staging (461) 461
survival analysis (448) 448
surgery (434) 434
disease progression (433) 433
kaplan-meier estimate (427) 427
progression-free (425) 425
survival rate (422) 422
clinical trials (417) 417
medicine & public health (402) 402
development and progression (371) 371
patient outcomes (368) 368
hematology, oncology and palliative medicine (366) 366
young adult (360) 360
rituximab (341) 341
medical prognosis (332) 332
carcinoma (321) 321
time factors (318) 318
radiotherapy (314) 314
follow-up studies (303) 303
risk factors (299) 299
progression free survival (294) 294
drug therapy (292) 292
bevacizumab (289) 289
trial (288) 288
adolescent (281) 281
health aspects (281) 281
phase-ii trial (280) 280
pharmacology & pharmacy (277) 277
breast cancer (275) 275
open-label (275) 275
neoplasm metastasis (271) 271
non-hodgkins-lymphoma (271) 271
recurrence (271) 271
transplantation (267) 267
cancer therapies (266) 266
proportional hazards models (264) 264
clinical neurology (263) 263
combined modality therapy (258) 258
phase-iii trial (254) 254
article (243) 243
biomarkers (240) 240
medical research (240) 240
ovarian cancer (237) 237
expression (236) 236
randomized controlled trials as topic (236) 236
phase-iii (234) 234
abridged index medicus (233) 233
phase-ii (231) 231
antineoplastic combined chemotherapy protocols - adverse effects (230) 230
mutation (226) 226
diagnosis (223) 223
immunotherapy (217) 217
metastases (214) 214
multivariate analysis (206) 206
lymphomas (205) 205
studies (205) 205
prospective studies (204) 204
radiology, nuclear medicine & medical imaging (203) 203
cisplatin (201) 201
colorectal cancer (201) 201
glioblastoma (200) 200
efficacy (199) 199
lung cancer (198) 198
neoplasms. tumors. oncology. including cancer and carcinogens (193) 193
usage (189) 189
lung neoplasms - drug therapy (188) 188
antineoplastic agents - administration & dosage (186) 186
randomized-trial (184) 184
toxicity (182) 182
antineoplastic agents (179) 179
radiation-therapy (178) 178
clinical-trials (177) 177
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4725) 4725
Chinese (59) 59
German (42) 42
Spanish (30) 30
French (29) 29
Korean (18) 18
Russian (15) 15
Japanese (10) 10
Polish (10) 10
Hungarian (7) 7
Czech (5) 5
Turkish (3) 3
Portuguese (2) 2
Dutch (1) 1
Esperanto (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2018, Volume 36, Issue 8, pp. 728 - 734
PurposeIn the ASPIRE study of carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide plus dexamethasone (Rd) in patients with relapsed or... 
DARATUMUMAB | TRIALS | THERAPY | ONCOLOGY | PROGRESSION-FREE SURVIVAL | FOLLOW-UP | ENDEAVOR | OPEN-LABEL | BORTEZOMIB | ASPIRE | Index Medicus
Journal Article
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, ISSN 1742-7835, 03/2019, Volume 124, Issue 3, pp. 239 - 239
Journal Article
Oncologist, ISSN 1083-7159, 2019, p. theoncologist.2018-0672
Tumor growth rate (TGR; percent size change per month [%/m]) is postulated to be an early radiological biomarker to overcome limitations of RECIST. This study... 
NET | Neuroendocrine tumor | Progression-free survival | Tumor growth rate | TGR
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 04/2012, Volume 9, Issue 4, pp. 199 - 207
Modern oncology drug development faces challenges very different from those of the past and it must adapt accordingly. The size and expense of phase III... 
DESIGN | SURROGATE | ONCOLOGY | PROGRESSION-FREE SURVIVAL | Clinical trials | Care and treatment | Usage | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2018, Volume 29, Issue 5, pp. 1220 - 1226
Abstract Background Paclitaxel is currently only available as an intravenous (i.v.) formulation. DHP107 is a novel oral formulation of lipid ingredients and... 
DHP107 | Oral paclitaxel | Gastric cancer | Non-inferiority | Progression free survival
Journal Article
European Radiology, ISSN 0938-7994, 2019
To determine the earliest optimal timing for assessment of early response following radioimmunotherapy in non-Hodgkin lymphoma patients using FDG-PET/CT.... 
Non-Hodgkin lymphoma | PET-CT | Progression-free survival | Radioimmunotherapy
Journal Article
Human Pathology, ISSN 0046-8177, 05/2017, Volume 63, pp. 46 - 52
Glioma is the most common type of malignant neoplasm in the central nervous system, with high incidence and mortality rate. MicroRNAs, as a class of small... 
Biomarkers | miR-204 | Prognosis | Glioma | Overall survival | Progression-free survival
Journal Article
by Gerson, James N and Handorf, Elizabeth and Villa, Diego and Villa, Diego and Gerrie, Alina S and Gerrie, Alina S and Chapani, Parv and Chapani, Parv and Li, Shaoying and Jeffrey Medeiros, L and Medeiros, L Jeffrey and Wang, Michael I and Wang, Michael I and Cohen, Jonathon B and Calzada, Oscar and Churnetski, Michael C and Churnetski, Michael C and Hill, Brian T and Hill, Brian T and Sawalha, Yazeed and Hernandez-Ilizaliturri, Francisco J and Hernandez-Ilizaliturri, Francisco J and Kothari, Shalin and Kothari, Shalin and Vose, Julie M and Vose, Julie M and Bast, Martin A and Fenske, Timothy S and Narayana Rao Gari, Swapna and Gari, Swapna Narayana Rao and Maddocks, Kami J and Maddocks, Kami J and Bond, David and Bond, David and Bachanova, Veronika and Bachanova, Veronika and Kolla, Bhaskar and Kolla, Bhaskar and Chavez, Julio and Chavez, Julio and Shah, Bijal and Shah, Bijal and Lansigan, Frederick and Lansigan, Frederick and Burns, Timothy F and Burns, Timothy F and Donovan, Alexandra M and Donovan, Alexandra M and Wagner-Johnston, Nina and Wagner-Johnston, Nina and Messmer, Marcus and Messmer, Marcus and Mehta, Amitkumar and Mehta, Amitkumar and Anderson, Jennifer K and Anderson, Jennifer K and Reddy, Nishitha and Reddy, Nishitha and Kovach, Alexandra E and Kovach, Alexandra E and Landsburg, Daniel J and Landsburg, Daniel J and Glenn, Martha and Glenn, Martha and Inwards, David J and Inwards, David J and Karmali, Reem and Karmali, Reem and Kaplan, Jason B and Kaplan, Jason B and Caimi, Paolo F and Caimi, Paolo F and Rajguru, Saurabh and Rajguru, Saurabh and Evens, Andrew and Evens, Andrew and Klein, Andreas and Klein, Andreas and Umyarova, Elvira and Umyarova, Elvira and Pulluri, Bhargavi and Pulluri, Bhargavi and Amengual, Jennifer E and Amengual, Jennifer E and Lue, Jennifer K and Lue, Jennifer K and Diefenbach, Catherine and Diefenbach, Catherine and Fisher, Richard I and Fisher, Richard I and Barta, Stefan K
Journal of Clinical Oncology, ISSN 0732-183X, 2019, Volume 37, Issue 6, pp. 471 - 480
PURPOSEMantle cell lymphoma (MCL) is a B-cell lymphoma characterized by cyclin D1 expression. Autologous hematopoietic cell transplantation (AHCT)... 
PATHOGENESIS | IMMUNOCHEMOTHERAPY | MULTICENTER | IMPACT | THERAPY | RANDOMIZED-TRIALS | PATTERN | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | PROGRESSION-FREE SURVIVAL | TRANSPLANTATION
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 11/2016, Volume 34, Issue 32, pp. 3950 - 3950
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 11/2016, Volume 34, Issue 32, pp. 3951 - 3951
Journal Article
LEUKEMIA & LYMPHOMA, ISSN 1042-8194, 2018, Volume 59, Issue 8, pp. 1767 - 1768
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.